Stago Accelerates Its Growth with ARCHIMED and La Caisse

Back to list

Communication of April 29, 2026

For nearly eighty years, Stago has been developing solutions grounded in rigorous scientific standards, driven by a constant ambition: to support healthcare professionals and contribute to improved patient care. 

As a leading global player in hemostasis, the company has built its identity on a culture of excellence, recognized expertise, and a long-term vision. 

Today, Stago is entering a new phase in its history. 

Stago webinar: Bleeding disorders of unknown cause - challenges in diagnosis and patient management

Back to list

This webinar aims to provide clinicians, clinical pathologists, researchers, and laboratory professionals with practical guidance on accurately identifying patients with Bleeding disorders of unknown cause (BDUC) and effectively managing their bleeding risk.
This webinar aims to provide clinicians, clinical pathologists, researchers, and laboratory professionals with practical guidance on accurately identifying patients with Bleeding disorders of unknown cause (BDUC) and effectively managing their bleeding risk.

Stago Webinars: subtitles now available in 6 Languages

Back to list

With the launch of its new Stago Webinars platform, Diagnostica Stago is further enhancing the accessibility of its scientific content. From now on, webinars in replay benefit from multilingual subtitles, enabling a wider audience to access these educational resources, regardless of their country or language.
With the launch of its new Stago Webinars platform, Diagnostica Stago is further enhancing the accessibility of its scientific content. From now on, webinars in replay benefit from multilingual subtitles, enabling a wider audience to access these educational resources, regardless of their country or language.

Discover the new Stago Webinars platform

Back to list

The Stago Webinars website has been redesigned and is now online, offering an enriched and even more intuitive user experience. Developed to meet your needs, this redesigned platform brings together all of our webinars in one place and introduces a range of new features to make accessing and viewing content easier than ever.
The Stago Webinars website has been redesigned and is now online, offering an enriched and even more intuitive user experience. Developed to meet your needs, this redesigned platform brings together all of our webinars in one place and introduces a range of new features to make accessing and viewing content easier than ever.

Stago webinar: Disseminated intravascular coagulation (DIC) - An in-depth look for 2026

Back to list

Clinicians, clinical pathologists, researchers, and clinical laboratory staff will have the opportunity to deepen their knowledge of the pathophysiology of Disseminated intravascular coagulation (DIC) and the newly published ISTH definition and scoring system.
Clinicians, clinical pathologists, researchers, and clinical laboratory staff will have the opportunity to deepen their knowledge of the pathophysiology of Disseminated intravascular coagulation (DIC) and the newly published ISTH definition and scoring system.

Stago at WHX Labs Dubai 2026: Four days of innovation and networking

Back to list

Stago teams from Saudi Arabia, Turkey, Dubai, and headquarters participated in WHX Labs Dubai 2026, formerly known as Medlab Middle East. Held at the Dubai World Trade Centre, the event brought together over 35,000 professionals from 180 countries.
Stago teams from Saudi Arabia, Turkey, Dubai, and headquarters participated in WHX Labs Dubai 2026, formerly known as Medlab Middle East. Held at the Dubai World Trade Centre, the event brought together over 35,000 professionals from 180 countries.

Communication of March 4, 2026

Back to list

Dear valued Partner,
We are pleased to share an important update regarding Stago's future.

Stago has entered into an exclusive negotiations with ARCHIMED, a healthcare-focused investment firm and La Caisse, also active in the healthcare sector, to support the next phase of our growth. 

This step reflects a strategic decision to further strengthen Stago's long-term growth while preserving what has always defined us: scientific excellence, reliability, deep expertise in hemostasis, and a strong commitment to customer partnerships.

Stago webinar: Emerging biomarker for thrombotic risk stratification in coronary artery disease

Back to list

Clinicians, clinical pathologists, researchers, and clinical laboratory staff will have the opportunity to deepen their knowledge of the role of TF-positive platelets in arterial thrombosis and CAD progression, as well as their potential to improve thrombotic risk stratification beyond traditional models.
Clinicians, clinical pathologists, researchers, and clinical laboratory staff will have the opportunity to deepen their knowledge of the role of TF-positive platelets in arterial thrombosis and CAD progression, as well as their potential to improve thrombotic risk stratification beyond traditional models.

Stago enters into exclusive negotiations with ARCHIMED and La Caisse

Back to list

PRESS RELEASE: December 11, 2025

The Stago Group, a global leader in diagnostics and a specialist in hemostasis, announced today that it has entered into exclusive negotiations with a consortium led by ARCHIMED, an investment fund dedicated to the healthcare sector, with a view to acquiring a majority stake in the group. La Caisse (formerly Caisse de dépôt et Placement du Québec) would invest alongside ARCHIMED as a minority investor.

 

Stago's 2025 CSR Report is online

Back to list

The Stago Group’s commitment to sustainability takes a new step forward with the release of our latest CSR report. More comprehensive, concrete, and forward-looking, it reflects the collective efforts of our international teams and subsidiaries, and the growing integration of CSR into our daily actions and long-term vision.
The Stago Group’s commitment to sustainability takes a new step forward with the release of our latest CSR report. More comprehensive, concrete, and forward-looking, it reflects the collective efforts of our international teams and subsidiaries, and the growing integration of CSR into our daily actions and long-term vision.
Subscribe to